Quest PharmaTech Inc (V:QPT) — Market Cap & Net Worth
Market Cap & Net Worth: Quest PharmaTech Inc (QPT)
Quest PharmaTech Inc (V:QPT) has a market capitalization of $2.45 Million (CA$3.38 Million) as of September 17, 2026. Listed on the V stock exchange, this Canada-based company holds position #29861 globally and #1449 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Quest PharmaTech Inc's stock price CA$0.02 by its total outstanding shares 169129247 (169.13 Million). Also see QPT total assets for a full breakdown of the balance sheet.
Quest PharmaTech Inc Market Cap History: 2015 to 2026
Quest PharmaTech Inc's market capitalization history from 2015 to 2026. Data shows change from $7.34 Million to $2.45 Million (-6.18% CAGR). Also see Quest PharmaTech Inc cash flow conversion for how efficiently the company converts equity into cash flow.
Quest PharmaTech Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Quest PharmaTech Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Quest PharmaTech Inc share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
314.75x
Quest PharmaTech Inc's market cap is 314.75 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $13.46 Million | $2.57K | -$4.13 Million | 5238.62x | N/A |
| 2018 | $12.23 Million | $38.87K | -$5.09 Million | 314.75x | N/A |
Competitor Companies of QPT by Market Capitalization
Companies near Quest PharmaTech Inc in the global market cap rankings as of September 17, 2026. Review Quest PharmaTech Inc tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Quest PharmaTech Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #186 globally with a market cap of $130.44 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #353 globally with a market cap of $78.29 Billion USD.
- CSL Ltd (AU:CSL): Ranked #457 globally with a market cap of $59.82 Billion USD ( AU$84.54 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #506 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #186 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.44 Billion | $514.63 |
| #353 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $78.29 Billion | $774.11 |
| #457 | CSL Ltd | AU:CSL | $59.82 Billion | AU$174.26 |
| #506 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $143.77 |
Quest PharmaTech Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Quest PharmaTech Inc's market cap moved from $7.34 Million to $ 2.45 Million, with a yearly change of -6.18%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$2.45 Million | -50.00% |
| 2025 | CA$4.89 Million | +33.33% |
| 2024 | CA$3.67 Million | -50.00% |
| 2023 | CA$7.34 Million | -14.29% |
| 2022 | CA$8.56 Million | -30.00% |
| 2021 | CA$12.23 Million | -56.52% |
| 2020 | CA$28.14 Million | +76.92% |
| 2019 | CA$15.90 Million | +30.00% |
| 2018 | CA$12.23 Million | -9.09% |
| 2017 | CA$13.46 Million | -8.33% |
| 2016 | CA$14.68 Million | +100.00% |
| 2015 | CA$7.34 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Quest PharmaTech Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.45 Million USD |
| MoneyControl | $2.45 Million USD |
| MarketWatch | $2.45 Million USD |
| marketcap.company | $2.45 Million USD |
| Reuters | $2.45 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Quest PharmaTech Inc
Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. The company's lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16 for the potential cancer targets, including pancreatic, colon, leukemia, ovarian, and breast cancer. Quest PharmaTech Inc. is headquartered in Edmonton, Canada.